<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0010">
 <label>Table 2</label>
 <caption>
  <p>Peptide-based fusion inhibitors targeting gp41 and gp120.</p>
 </caption>
 <alt-text id="at0020">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left">Peptide Name</th>
    <th align="left">Sequence</th>
    <th align="left">Derived from</th>
    <th align="left">Target</th>
    <th align="left">IC
     <sub>50</sub> (nM)
    </th>
    <th align="left">Assay Format Tested</th>
    <th align="left">Phase</th>
    <th align="left">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">pV2α-Tys</td>
    <td align="left">KVQKEY(SO3H)ALFY(SO3H)-ELDIVPID</td>
    <td align="left">CCR5 N-terminus</td>
    <td align="left">Gp120 variable loops</td>
    <td align="left">50,000</td>
    <td align="left">CCR5-binding assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0200" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">pCCR5-Tys</td>
    <td align="left">MDYQVSSPIY(SO3H)DIANY(SO3H)YTSEPSQK</td>
    <td align="left">CCR5 N-terminus</td>
    <td align="left">Gp120 variable loops</td>
    <td align="left">50,000</td>
    <td align="left">CCR5-binding assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0200" ref-type="bibr">40</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">E1P47</td>
    <td align="left">WILEYLWKVPFDFWRGVI</td>
    <td align="left">GB virus C E1 protein</td>
    <td align="left">gp41 FP</td>
    <td align="left">8200</td>
    <td align="left">Competitive ELISA, fluorescence resonance energy transfer, haemolysis assays</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0360" ref-type="bibr">72</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">SC29EK</td>
    <td align="left">WEEWDKKIEEYTKKIEELIKKSEEQQKKN</td>
    <td align="left">gp41</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">9.6</td>
    <td align="left">multinuclear activation of galactosidase indicator (MAGI) assays</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0735" ref-type="bibr">147</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">FB006M</td>
    <td align="left">Ac-WEEWDREINNYTK (MPA)LIHELIEESQNQQEKNEQELL-CONH2</td>
    <td align="left">Gp41 CHR</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">2.7</td>
    <td align="left">peripheral blood mononuclear cell (PBMC) assay, ELISA</td>
    <td align="left">Approved</td>
    <td align="left">[
     <xref rid="bib1110" ref-type="bibr">222</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">CP32M</td>
    <td align="left">VEWNEMTWMEWEREIENYTKLIYKILEESQEQ</td>
    <td align="left">gp41 CHR</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">65</td>
    <td align="left">Native Polyacrylamide Gel Electrophoresis (N-PAGE) Assay, Cell–Cell Fusion Assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0425" ref-type="bibr">85</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">HP23</td>
    <td align="left">EMTWEEWEKK IEEYTKKIEEILK</td>
    <td align="left">Gp41 CHR</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">4.7</td>
    <td align="left">Cell-cell fusion assay, Pierce firefly luciferase glow assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1115" ref-type="bibr">223</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">AP3</td>
    <td align="left">KKISEEQKKIQEEIKKILEESKKILEEIKKDWEEWTM</td>
    <td align="left">artificial peptide</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">13∼90</td>
    <td align="left">ELISA</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib1170" ref-type="bibr">234</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">N36Fd</td>
    <td align="left">SGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILGYIPEAPRDGQAYVRKDGEWVLLSTFL</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">Gp41 CHR</td>
    <td align="left">99</td>
    <td align="left">Cell-Cell Fusion, ELISA, luciferase assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0500" ref-type="bibr">100</xref>]
    </td>
   </tr>
   <tr>
    <td align="left">N28Fd</td>
    <td align="left">IEAQQHLLQLTVEGIKQLQARILAVERYGYIPEAPRDGQAYVRKDGEWVLISTFL</td>
    <td align="left">Gp41 NHR</td>
    <td align="left">Gp41 CHR</td>
    <td align="left">39</td>
    <td align="left">Cell-Cell Fusion, ELISA, luciferase assay</td>
    <td align="left">Pre-clinical</td>
    <td align="left">[
     <xref rid="bib0500" ref-type="bibr">100</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
